MX1 - 2026 Appendix 4E and Annual Report
Filed with ASX · · 92 pages · English
Summary by 6ix AI
The report highlights a revenue increase from ordinary activities, while also noting a significant loss attributable to the owners of Micro-X. No dividends were declared during the current financial period, and the report includes an audit qualification regarding going concern. The filing emphasizes the company's focus on advancing its medical imaging technology and improving commercial outcomes moving forward.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Story so far
Earlier from Micro-X
- MX1 - Management Update & Convertible Note Issue
- MX1 - Micro-X Completes Full Body CT Critical Design Review
- MX1 - Human Imaging Study Commences with Micro-X Head CT
- $1.3m Checkpoint Contract Extension Awarded by DHS
- MX1 - First Full Body CT Laboratory Test Bench Completed
Later from Micro-X
- Response to ASX Price Query
- MX1 - DHS CT Baggage Scanner Contract Extension
- MX1 - Quarterly Activities Report & Appendix 4C
Follow Micro-X into a list and get an email when it puts out news.
Follow Micro-X